Clinical Significance of Lymphoid Enhancer-Binding Factor 1 (LEF-1) Expression in Acute Myeloid Leukemia

Correlation between SOX2 and Mutant IDH1 Protein Expression in Astrocytomas and their Clinicopathologic Significance

Does Fibrinogen Like Protein 2 Play A Role in High-Grade Glioma as A Prognostic Factor?

PDGFRA EXPRESSION IN ADULT ASTROCYTOMA AND ITS RELATION TO CELL CYCLE REGULATORS; P53 AND CYCLIN D1

THE TUMOR SUPPRESSOR NDRG2 DISRUPTS THE ONCOGENICITY OF THE CYTOPLASMIC PRMT5 IN ATL LEUKEMIA

Lymphoid enhancer binding factor-1 (LEF1): as a prognostic factor in patients with Chronic lymphocytic leukemia

Significance of tumor necrosis factor- α and B2 microglobulin in patients having chronic lymphocytic leukemia

The Role of Expression of Lymphoid Enhancer-Binding Factor-1 (LEF-1) in Patients with Chronic Lymphocytic Leukemia

Clinicopathologic Significance of Fascin Expression in Different Grades of Gliomas

EVALUATION OF THE ROLE OF MUTANT IDH1, EGFR AND BCL2 PROTEIN EXPRESSION IN DISTINGUISHING DIFFUSE ASTROCYTOMA FROM ASTROCYTOSIS